Literature DB >> 23074737

Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23074737

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  9 in total

1.  Computational prediction of vaccine strains for human influenza A (H3N2) viruses.

Authors:  L Steinbrück; T R Klingen; A C McHardy
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

2.  Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins.

Authors:  Hua Yang; Jessie C Chang; Zhu Guo; Paul J Carney; David A Shore; Ruben O Donis; Nancy J Cox; Julie M Villanueva; Alexander I Klimov; James Stevens
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

3.  Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years.

Authors:  Dorothee Kieninger; Eric Sheldon; Wen-Yuan Lin; Chong-Jen Yu; Jose M Bayas; Julian J Gabor; Meral Esen; Jose Luis Fernandez Roure; Silvia Narejos Perez; Carmen Alvarez Sanchez; Yang Feng; Carine Claeys; Mathieu Peeters; Bruce L Innis; Varsha Jain
Journal:  BMC Infect Dis       Date:  2013-07-24       Impact factor: 3.090

4.  4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany.

Authors:  Martin Eichner; Markus Schwehm; Johannes Hain; Helmut Uphoff; Bernd Salzberger; Markus Knuf; Ruprecht Schmidt-Ott
Journal:  BMC Infect Dis       Date:  2014-07-03       Impact factor: 3.090

5.  Implementation of influenza-like illness sentinel surveillance in Togo.

Authors:  Issaka Maman; Kossi Badziklou; Essoya D Landoh; Afiwa W Halatoko; Talla N Nzussouo; Gabriel N Defang; Tsidi A Tamekloe; Pamela J Kennedy; Williams Thelma; Komlan Kossi; Zoulkarneiri Issa; Abiba B Kere
Journal:  BMC Public Health       Date:  2014-09-20       Impact factor: 3.295

6.  Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic.

Authors:  Kannan Tharakaraman; Rahul Raman; Nathan W Stebbins; Karthik Viswanathan; Viswanathan Sasisekharan; Ram Sasisekharan
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.

Authors:  Joanne M Langley; Alfonso Carmona Martinez; Archana Chatterjee; Scott A Halperin; Shelly McNeil; Keith S Reisinger; Naresh Aggarwal; Li-Min Huang; Ching-Tien Peng; José Garcia-Sicilia; Ignacio Salamanca de la Cueva; Fernando Cabañas; Consuelo Treviño-Garza; Miguel Angel Rodríguez-Weber; Manuel de la O; Vijayalakshmi Chandrasekaran; Walthère Dewé; Aixue Liu; Bruce L Innis; Varsha K Jain
Journal:  J Infect Dis       Date:  2013-07-11       Impact factor: 5.226

8.  Survey of causative agents for acute respiratory infections among patients in Khartoum-State, Sudan, 2010-2011.

Authors:  Khalid A Enan; Takeshi Nabeshima; Toru Kubo; Corazon C Buerano; Abdel Rahim M El Hussein; Isam M Elkhidir; Eltahir A G Khalil; Kouichi Morita
Journal:  Virol J       Date:  2013-10-25       Impact factor: 4.099

9.  Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season.

Authors:  Xi Li; Michael W Deem
Journal:  Protein Eng Des Sel       Date:  2016-06-16       Impact factor: 1.650
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.